Host cell reactivation of cisplatin-damaged plasmid DNA in human non-T leukocyte cell lines
- 15 April 1992
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 63 (2) , 143-150
- https://doi.org/10.1016/0304-3835(92)90064-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Platinum—DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometryCarcinogenesis: Integrative Cancer Research, 1991
- Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.Journal of Clinical Investigation, 1991
- Host-cell reactivation of cisplatin-damaged pRSVcat in a human lymphoid cell lineCarcinogenesis: Integrative Cancer Research, 1990
- DNA repair in cells sensitive and resistant to cis-diamminedichloroplatinum(II): host-cell reactivation of damaged plasmid DNABiochemistry, 1989
- The measurement of cisplatin-DNA adduct levels in testicular cancer patientsCarcinogenesis: Integrative Cancer Research, 1988
- Mechanisms of cellular resistance to cisplatinMedical Oncology and Tumor Pharmacotherapy, 1988
- Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy.Journal of Clinical Investigation, 1986
- Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II)Biochemistry, 1983
- Clonal differences in response to T cell replacing factor (TRF) for IgM secretion and TRF receptors in a human B lymphoblast cell lineEuropean Journal of Immunology, 1983
- IgM and IgG secretion in human B-cell lines regulated by B-cell-inducing factors (BIF) and phorbol esterImmunology Letters, 1983